Pain Relief
- Product NDC
- 21130-608
- 11-digit product format
- 211300608
- Labeler code
- 21130
- Product ID
- 21130-608_fd39cb89-6b3f-69e1-e053-6394a90aff3a
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Naproxen sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- BETTER LIVING BRANDS, LLC
- Application
- ANDA090545
- Marketing category
- ANDA
- Marketing start
- 2023-06-13
- Substance
- NAPROXEN SODIUM
- Active strength
- 220 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 9TN87S3A3C | NAPROXEN SODIUM | 26159-34-2 | NAPROXEN SODIUM |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 21130-608-05 | 21130060805 | 1 BOTTLE in 1 CARTON (21130-608-05) / 50 TABLET in 1 BOTTLE | 1 bottle | 2023-06-13 | No | No | Historical |
| 21130-608-20 | 21130060820 | 200 TABLET in 1 BOTTLE (21130-608-20) | 200 tablet | 2023-06-13 | No | No | Historical |
| 21130-608-42 | 21130060842 | 1 BOTTLE in 1 CARTON (21130-608-42) / 24 TABLET in 1 BOTTLE | 1 bottle | 2023-06-13 | No | No | Historical |